Lung metastases at the initial diagnosis of high-grade osteosarcoma: prevalence, risk factors and prognostic factors. A large population-based cohort study
暂无分享,去创建一个
Chao Zhang | Xu Guo | Yao Xu | Xiuxin Han | Xin Wang | Guo-wen Wang | Jun Cai
[1] Zhang-Yuan Lin,et al. CXCR4‐mediated osteosarcoma growth and pulmonary metastasis is suppressed by MicroRNA‐613 , 2018, Cancer science.
[2] Q. Guo,et al. The homogeneous and heterogeneous risk factors for the morbidity and prognosis of bone metastasis in patients with prostate cancer , 2018, Cancer management and research.
[3] Jingnan Shen,et al. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma , 2015, Oncotarget.
[4] C. Bandala,et al. Association of Metastasis with Clinicopathological Data in Mexican Patients with Osteosarcoma, Giant Cell Tumor of Bone and Chondrosarcoma. , 2015, Asian Pacific journal of cancer prevention : APJCP.
[5] B. Fuchs,et al. Expression of the Chemokine Receptor CXCR7 in CXCR4-Expressing Human 143B Osteosarcoma Cells Enhances Lung Metastasis of Intratibial Xenografts in SCID Mice , 2013, PloS one.
[6] J. Buckwalter,et al. Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database. , 2013, The Journal of bone and joint surgery. American volume.
[7] N. Daw,et al. Survival of pediatric patients after relapsed osteosarcoma: The St. Jude Children's Research Hospital experience , 2008, Cancer.
[8] M. van Glabbeke,et al. Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials. , 2011, European journal of cancer.
[9] L. Koniaris,et al. Osteosarcoma: improvement in survival limited to high-grade patients only , 2011, Journal of Cancer Research and Clinical Oncology.
[10] H. Gelderblom,et al. Prognostic factors in pulmonary metastasized high‐grade osteosarcoma , 2009, Pediatric blood & cancer.
[11] A. D. Dei Tos,et al. Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] M. Blackstein,et al. Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[13] I. Munajat,et al. Tumour Volume and Lung Metastasis in Patients with Osteosarcoma , 2008, Journal of orthopaedic surgery.
[14] P. Choong,et al. A review of clinical and molecular prognostic factors in osteosarcoma , 2008, Journal of Cancer Research and Clinical Oncology.
[15] M. Semik,et al. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] W. Winkelmann,et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] J. W. van der Eijken,et al. Osteosarcoma over the age of forty. , 2003, European journal of cancer.
[18] W. Winkelmann,et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] W. Winkelmann,et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] A. Huvos,et al. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.